LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Étude D-CBP : Évaluation des délais de prise en charge du cancer broncho- pulmonaire au sein du service de Pneumologie et d’Oncologie Thoracique du CHU de Caen.

Deshayes, S / Leite Ferreira, D / Madelaine, J / Oulkhouir, Y / Campbell, K / Fouquet, H / Teulier, S / Magnier, R / Heyndrickx, M / Lerouge, D / Bergot, E / Justet, A

Revue des maladies respiratoires

2021  Band 38, Heft 9, Seite(n) 894–903

Abstract: Introduction: Lung cancer is the leading cause of cancer-related death. Delays may have an impact on patient survival. The objective of this study was to evaluate the diagnostic and therapeutic management times for patients admitted for lung cancer ... ...

Titelübersetzung D-CBP study: Evaluation of lung cancer management times.
Abstract Introduction: Lung cancer is the leading cause of cancer-related death. Delays may have an impact on patient survival. The objective of this study was to evaluate the diagnostic and therapeutic management times for patients admitted for lung cancer treatment in the Respiratory Department of CHU de Caen Normandie.
Materials and methods: This is a retrospective, single-center and observational study, conducted on all patients treated for lung cancer from June 2017 to January 2018 in our department of pneumology in the Caen Normandie CHU. The main median times were investigated were: Global Time (abnormal imaging-treatment), Diagnosis time (abnormal imaging-diagnosis) and Treatment Time (diagnosis-treatment).
Results: One hundred and twenty-seven (127) patients were included. Median global time was 55.5 days [31,25; 393], median diagnosis time was 22 days [13; 49], and median treatment time was 24.5 days [12,25; 45].
Discussion: Our treatment times are consistent with those previously published. Areas for improvement are being developed in accordance with the 2014-2019 cancer plan, in particularly the creation in our institution of a specific care pathway for patients with lung cancer.
Mesh-Begriff(e) Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/epidemiology ; Lung Neoplasms/therapy ; Retrospective Studies ; Time Factors
Sprache Französisch
Erscheinungsdatum 2021-10-28
Erscheinungsland France
Dokumenttyp Journal Article ; Observational Study
ZDB-ID 605743-3
ISSN 1776-2588 ; 0301-0279 ; 0761-8425
ISSN (online) 1776-2588
ISSN 0301-0279 ; 0761-8425
DOI 10.1016/j.rmr.2021.09.002
Signatur
Zs.A 1945: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MO 94: Hefte anzeigen
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang